Ramy Riad | President, Plasma-Derived Therapies

Ramy Riad, MBA, is the president of Takeda’s Plasma-Derived Therapies (PDT) Business Unit.

A global biopharmaceutical leader with more than 20 years of experience spanning strategy, finance, operations and market access, Ramy brings deep expertise in the plasma industry.

Most recently, he served as the senior vice president and CFO, Finance, Strategy, and Operations for the PDT Business Unit, where he helped shape Takeda’s end-to-end plasma value chain strategy. He also helped build an integrated operating model spanning plasma collection, manufacturing, R&D, strategy and commercial operations—strengthening alignment, accountability and performance through significant industry and supply chain disruption during the COVID-19 pandemic. Earlier at Takeda, Ramy led international commercial finance across eight regions, 106 countries, and 60 affiliates, driving commercial execution, market penetration, and organizational integration.

Prior to joining Takeda, he held multiple leadership roles at Abbott, Merck, and Sanofi Aventis, working across global market access, pricing, reimbursement, and institutional strategy.

Ramy holds an MBA in Finance from Southern New Hampshire University and a bachelor’s degree in Accounting and Business Administration from Cairo University.